Latest News

Study reveals TWEAK-Fn14 as key drug target

A cellular pathway interaction known as TWEAK-Fn14, often associated with repair of acute injuries, also is a viable target for drug therapy that could prevent the spread of cancer, especially brain cancer, according to a study.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Report recommends insurers use prescription monitoring data to reduce opioid abuse, deaths

  • Almost one-third of Canadian adults have experienced child abuse

  • Coming up with explanations helps children develop cause-and-effect thinking skills

  • Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches

  • Stroke treatment, outcomes improve with new initiative

  • Newly-approved brain stimulator offers hope for individuals with uncontrolled epilepsy

  • Cyber buddy is better than 'no buddy'

  • Innovation improves drowsy driver detection

  • Multiple sclerosis: Review of current treatments for physicians

  • Researchers compare hip width and sexual behavior

  •